celltrion

Broadly Neutralizing Influenza Antibody Found

Researchers have isolated a broadly neutralizing influenza antibody from convalescent patients, sparking hopes for a better vaccine.

Celltrion Files For FDA Approval For Biosimilar Drug

Celltrion predicts that it is one year away from approval for Remsima®, a biosimilar based on an originator drug from Janssen Biotech.